|
|
Volumn 106, Issue 6 SUPPL., 1994, Pages 348S-354S
|
|
Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung: LCSG 881
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEXAMETHASONE;
DIPHENHYDRAMINE;
FUROSEMIDE;
LORAZEPAM;
MANNITOL;
METOCLOPRAMIDE;
MITOMYCIN;
VINBLASTINE;
ADULT;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ESOPHAGITIS;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
OTOTOXICITY;
PHASE 2 CLINICAL TRIAL;
POSTOPERATIVE COMPLICATION;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
RADIATION SICKNESS;
RANDOMIZED CONTROLLED TRIAL;
SURGICAL MORTALITY;
|
|
EID: 0028054239
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.106.6.348S Document Type: Article |
|
Times cited : (46)
|
|
References (0)
|
